OncoTherapy Science4564 
$0.31-4.26%24h
-4.26%24h
Global rank23627
Market cap$59.16M
Change 7d7.14%
YTD Performance95.65%
SP500 benchmarkOutperform
P/E-0.05
P/S7.64
Revenue$7.74M
Earnings-$7.63M
Dividend yield-
Main Sector
Healthcare
EPS for OncoTherapy Science (4564)
OncoTherapy Science has an EPS of $-5.81. In 2022, the company made an earnings per share (EPS) of $-13.72. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
EPS for 4564
-
Value:-
EPS history for OncoTherapy Science from 2001 to 2023
| Year | EPS | Change |
|---|---|---|
| 2023 | -$5.81 | -57.65% |
| 2022 | -$13.72 | 54.85% |
| 2021 | -$8.86 | -35.47% |
| 2020 | -$13.73 | - |
View the highest EPS stocks
